The Forefront for Novel Therapeutic Agents Based on the Pathophysiology of Lower Urinary Tract Dysfunction: Bladder Selectivity Based on In Vivo Drug–Receptor Binding Characteristics of Antimuscarinic Agents for Treatment of Overactive Bladder-Reference-Cited by-同舟云学术

The Forefront for Novel Therapeutic Agents Based on the Pathophysiology of Lower Urinary Tract Dysfunction: Bladder Selectivity Based on In Vivo Drug–Receptor Binding Characteristics of Antimuscarinic Agents for Treatment of Overactive Bladder

Published:2010 Issue:2 Volume:112 Page:142-150
ISSN:1347-8613
Container-title:Journal of Pharmacological Sciences
language:en
Short-container-title:J Pharmacol Sci

Author:

Yoshida Akira,Fujino Tomomi,Maruyama Shuji,Ito Yoshihiko,Taki Yuko,Yamada Shizuo

Publisher

Japanese Pharmacological Society

Subject

Pharmacology,Molecular Medicine

Reference74 articles.

1. 1 Wein AJ, Rovner ES. Definition and epidemiology of overactive bladder. Urology. 2002;60:7–12.

2. 2 Anderson KE. Pharmacology of lower urinary tract smooth muscles and penile erectile tissues. Pharmacol Rev. 1993;45:253–308.

3. 3 Andersson KE. Antimuscarinics for treatment of overactive bladder. Lancet Neurol. 2004;3:46–53.

4. 4 Ouslander JG. Management of overactive bladder. N Engl J Med. 2004;350:786–799.

5. 5 Pakulski C, Drobnik L, Millo B. Age and sex as factors modifying the function of the blood-cerebrospinal fluid barrier. Med Sci Monit. 2000;6:314–318.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmcokinetic and pharmacodynamic considerations for the anticholinergic burden scale of drugs;Geriatrics & Gerontology International;2023-10-23

2. Risk of delirium associated with antimuscarinics in older adults: A case‐time‐control study;Pharmacoepidemiology and Drug Safety;2022-05-25

3. Comparative characterization of β-adrenoceptors in the bladder, heart, and lungs of rats: Alterations in spontaneously hypertensive rats;Journal of Pharmacological Sciences;2022-01

4. Possible Involvement of Muscarinic Receptor Blockade in Mirabegron Therapy for Patients with Overactive Bladder;Journal of Pharmacology and Experimental Therapeutics;2021-03-03

5. Association between anticholinergic burden and anticholinergic adverse outcomes in the elderly: Pharmacological basis of their predictive value for adverse outcomes;Pharmacological Research;2021-01